From the Journals

Lipid-Derived Biomarkers for NAION

TVST study reveals potential new metabolic signal in nonarteritic anterior ischemic optic neuropathy

  • March 13, 2026

  • 4 min

Share

Nonarteritic anterior ischemic optic neuropathy (NAION) is a challenging condition in ophthalmology lacking definitive diagnostic biomarkers. A recent study published in Translational Vision Science & Technology explored the potential of two lipid-derived indices, the atherogenic index of plasma (AIP) and the triglyceride–glucose (TyG) index, as systemic biomarkers associated with NAION. The case–control study involving 44 NAION patients revealed elevated AIP and TyG levels compared to controls, suggesting that systemic metabolic vulnerabilities might predispose individuals to NAION, although further research is necessary for clinical application.

Original Source(s)

Lipid-Derived Biomarkers for NAION

  • March 13, 2026

Related Content

Hydrus®: Designed with Purpose

Professor Norbert Pfeiffer explores the features and benefits of the Hydrus® Microstent

  • March 13, 2026

  • 4 min
Rayner Expands US Cataract Platform with Anikavisc Acquisition

Strengthens Rayner’s US cataract portfolio with a fully bundled OVD, IOL and phaco offering

  • March 13, 2026

  • 2 min
Cataract Surgeons Gain a New Lens Tool

An extended depth of focus intraocular lens approved by the FDA is designed to improve visual range while maintaining contrast sensitivity in cataract surgery.